Clinical Trial Update: Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)

View source ↗

Summary

METABREC (NCT04654975) is a clinical trial investigating brain metastases after esophagectomy for esophageal cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Esophageal Cancer

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Esophageal Neoplasms, Esophagectomy | Status: RECRUITING